Short Interest in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Decreases By 27.2%

Short Interest in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Decreases By 27.2%

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) was the recipient of a large decline in short interest in February. As of February 28th, there was short interest totalling 2,600,000 shares, a decline of 27.2% from the February 13th total of 3,570,000 shares. Based on an average daily volume of 562,300 shares, the days-to-cover ratio is currently 4.6 days. Approximately 13.1% of the shares of the company are short sold.